Introduction
CDK4/6 inhibitors in the continuum of care for HR+ HER2- Breast Cancer
Objectives
1. Recent updates about CDK4/6 inhibitors in the adjuvant setting
2. Strategies for side effect management and improving patient adherence when using CDK 4/6 inhibitors
This Course For :
Physician
( Internal Medicine , Oncology , General practitioner )
Resident / Fellow
( Internal Medicine , Oncology , General practitioner )
Speaker
Dr Hashem Alhashem
Consultant Medical Oncology, King Saud University Medical City.
Designated Institutional Official (DIO), Riyadh First Health Cluster, Ministry of Health
Associate Executive Director for Academic Affairs Riyadh First Health Cluster, Ministry of Health
Dr Abdul Naser Souhil
Consultant Medical Oncology, Almanea Hospital at Dammam, Kingdom of Saudi Arabia.
Dr Taleb Buhlaiaqh
Consultant Medical Oncology, Head of Medical Oncology division, Program Director of Medical Oncology Fellowship at Prince Sultan Medical Military city at Riyadh.
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
22 May 2024 To 22 May 2024 -
07:30 PM To 09:00 PM 
Certificate Available 
SCFHS 2 CME hours
Online
Add to Calendar
05/22/2024 07:30 PM
05/22/2024 09:00 PM
Asia/ Riyadh
Cyclin-dependent kinase 4/6 inhibitors in the continuum of care for hormone receptor-positive and human epidermal growth factor receptor-2 negative
Cyclin-dependent kinase 4/6 inhibitors in the continuum of care for hormone receptor-positive and human epidermal growth factor receptor-2 negative
https://medicalacademy.org/portal/event/view/2093
